Optimizing clinical trials involves adopting adaptive trial designs and utilizing real-world evidence to complement traditional randomized controlled trials. Digital tools for patient recruitment and monitoring can also enhance efficiency and reduce costs. Furthermore, integrating biomarkers and other molecular data can help in identifying the most suitable participants for specific treatments.
